Abstract
Background
Lymphatic mapping and sentinel node biopsy in breast cancer aims to allow lymph node negative women to avoid axillary clearance by providing a minimally invasive means of staging the axilla. However, before its implementation into routine clinical practice, initiating departments must verify their expertise in each of the surgical, radiological and pathological components necessary for its successful performance. Here, we present our validation experience.
Methods
Thirty patients with breast cancer of any stage (but without clinical axillary lymphadenopathy) undergoing definitive resection of their primary tumour underwent lymphatic mapping (using blue dye alone or in combination with radioisotope) and sentinel node biopsy concurrent with standard level II axillary clearance over a ten month period.
Results
All patients had sentinel nodes identified intraoperatively.The sentinel node in 29 patients correctly predicted the status of axillary involvement. One patient had non-sentinel nodal disease without metastases being identified in their sentinel node. Such a singlefalse negative out of thirty patients is considered acceptable by current guidelines.
Conclusion
Validation of expertise in sentinel node identification and analysis is feasible over a relatively short period of time in a regional symptomatic breast unit. We now feel confident in offering this procedure to selected patients with breast cancer in our catchment area in place of routine axillary clearance.
Similar content being viewed by others
References
Guenther JM, Hansen NM, DiFronzo LA, et al. Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes.Arch Surg 2003;138: 52–56.
Nugent N, Hill ADK, Casey M, et al. Safety guidelines for radiolocalised sentinel node resection.Ir J Med Sci 170; 4: 236–238.
Beenkein SW, Urist MM, Zhang Y, et al. Axillary lymph node status, but not tumour size, predicts locoregional recurrence and overall survival after mastectomy for breast cancer.Ann Surg 2003; 237 (5): 732–739.
Van der Wal BCH, Butzelaar MJM, van der Miej, Boermeester MA. Axillary lymph node ratio and total number of removed nodes: predictors of survival in stage I and II breast cancer.EJSO 2002; 28: 481–489.
Gervasoni JE, Taneja C, Chung MA, Cady B. Axillary dissection in the context of the biology of lymph node metastases.Am J Surg 2000; 180: 278–283.
De Kanter AY, van Eijck CH, van Geel AN et al. Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer.Br J Surg 1999; 86 (11): 1459–1462.
Noguchi M. Sentinel node biopsy and breast cancer.Br J Surg 2002;89: 21–34.
Blanchard DK, Donohue JH, Reynolds C, Grant CS. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer.Arch Surg 2001; 138: 482–488.
Sener SF, Winchester DJ, Martz CH, et al. Lymphedema after sentinel lymphadenopathy for breast carcinoma.Cancer 2001: 92: 748–752.
Rutgers EJ, Nieweg OE. Finding lymph node metastases in invasive breast cancer: sampling or sentinel node procedure?EJSO 2002; 28: 569–570
Whitworth P, McMasters KM, Tafra L, Edwards MJ. State-of-the-art lymph node staging for the breast cancer in the year 2000.Am J Surg 2000; 180: 262–267.
Nieweg OE, Rutgers EJ, Jansen L, et al. Is lymphatic mapping in breast cancer adequate and safe.World J Surg 2001; 25: 780–788.
Karamlou T, Johnson NM, Chan B, Franzini D, Mahin D. Accuracy of intraoperative touch imprint cytologic analysis of sentinel lymph nodes in breast cancer.Am J Surg 2003 May; 185(5): 425–428.
Mullenix PS, Carter PL, Martin MJ, et al. Predictive value of intraoperative touch preparation analysis of sentinel lymph nodes for axillary metastasis in breast cancer.Am J Surg 2003 May;185(5): 420–424.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cahill, R.A., Diamond, L., Landers, R. et al. Validation of lymphatic mapping and sentinel node biopsy in patients with symptomatic breast cancer. Ir J Med Sci 175, 59–62 (2006). https://doi.org/10.1007/BF03167952
Issue Date:
DOI: https://doi.org/10.1007/BF03167952